David Shum (Hakim Djaballah)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

High Throughput

Single Molecule

Tyrosine Kinase

Cell Cycle Arrest

Top Venues

GEN biotechnology

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

David Shum, Bhavneet Bhinder, Jeni Mahida, Constantin Radu, Paul A Calder, Hakim Djaballah
A Genome-Wide RNAi Screen Reveals Common Host-Virus Gene Signatures: Implication for Dengue Antiviral Drug Discovery. GEN biotechnology 2 (2) (2023)
Thapi D Rao, Mengyao Xu, Stephanie Eng, Guangli Yang, Robin Manson, Nestor Rosales, Raj Kumar, Irva E Veillard, Qin C Zhou, Alexia Iasonos, Ouathek Ouerfelli, David Shum, David R Spriggs, Oladapo O Yeku
Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents. Molecular cancer therapeutics 21 (5) (2022)
Christina V Angeles, Ana Velez, Jordan Rios, Bernadette Laxa, David Shum, Penelope D Ruiz, Yawei Shen, Irina Ostrovnaya, Rodrigo Gularte-Mérida, Benjamin A Nacev, Mark A Dickson, David Shum, Tomoyo Okada, Samuel Singer
A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)